Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for TRAMADOL HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 16
  • 0 comments

Labeling changes approved for SUN PHARM INDS INC. Active ingredient: TRAMADOL HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for TRAMADOL HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 25
  • 0 comments

Labeling changes approved for TEVA. Active ingredient: TRAMADOL HYDROCHLORIDE. Decision date: 12/11/2025

Comment Full text

FDA updates labeling for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 22
  • 0 comments

Labeling changes approved for WATSON LABS. Active ingredient: NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 29
  • 0 comments

Labeling changes approved for SUN PHARM INDS LTD. Active ingredient: NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE. Decision date: 12/15/2025

Comment Full text

FDA approves NUZOLVENCE from ENTASIS THERAP

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 20
  • 0 comments

Final approval of NDA #NDA #219491 for ZOLIFLODACIN. Decision date: 12/12/2025

Comment Full text

FDA updates labeling for THALLOUS CHLORIDE TL 201

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 11
  • 0 comments

Labeling changes approved for CURIUM. Active ingredient: THALLOUS CHLORIDE TL-201. Decision date: 12/10/2025

Comment Full text

FDA approves manufacturing change for NISOLDIPINE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 27
  • 0 comments

Manufacturing process update for AMTA. Submission: SUPPL-2. Decision date: 12/12/2025

Comment Full text

FDA regulatory update for ROLVEDON

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 21
  • 0 comments

Administrative update #SUPPL-11 for SPECTRUM PHARMS. Status: Approval. Decision date: 12/12/2025

Comment Full text

FDA updates labeling for MOMETASONE FUROATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 15
  • 0 comments

Labeling changes approved for FOUGERA PHARMS. Active ingredient: MOMETASONE FUROATE. Decision date: 12/10/2025

Comment Full text

FDA updates labeling for MEROPENEM

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 24
  • 0 comments

Labeling changes approved for BROOKS STERISCIENCE. Active ingredient: MEROPENEM. Decision date: 12/11/2025

Comment Full text
  • Previous
  • 37
  • 38
  • 39
  • 40
  • 41
  • Next

Search

News categories

  • Technical Exchange News(11257)
  • Event(2616)
  • SEC News(198392)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131560)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin